Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MyMedCards ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   7.3% 5.3% 3.0% 2.5% 2.4% 3.3% 9.1% 9.1%   Credit score (0-100)   34 42 56 62 62 55 27 27   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,244 1,560 2,178 3,504 4,808 9,819 0.0 0.0   EBITDA   56.1 518 933 1,377 1,532 4,263 0.0 0.0   EBIT   -321 91.4 507 1,027 1,206 4,160 0.0 0.0   Pre-tax profit (PTP)   -324.2 75.7 503.2 1,024.3 1,218.7 4,203.3 0.0 0.0   Net earnings   -252.9 76.5 392.4 797.9 939.9 3,269.3 0.0 0.0   Pre-tax profit without non-rec. items   -324 75.7 503 1,024 1,219 4,203 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   515 591 984 1,782 2,721 3,991 1,810 1,810   Interest-bearing liabilities   485 122 120 87.0 36.8 0.0 0.0 0.0   Balance sheet total (assets)   1,639 1,956 2,293 2,990 4,028 6,391 1,810 1,810   Net Debt   485 -288 -99.7 -1,190 -2,649 -3,408 -1,810 -1,810     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,244 1,560 2,178 3,504 4,808 9,819 0.0 0.0   Gross profit growth   151.8% 25.4% 39.6% 60.9% 37.2% 104.2% -100.0% 0.0%   Employees   3 3 3 4 5 8 0 0   Employee growth %   0.0% 0.0% 0.0% 33.3% 25.0% 60.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,639 1,956 2,293 2,990 4,028 6,391 1,810 1,810   Balance sheet change%   -1.3% 19.4% 17.3% 30.4% 34.7% 58.7% -71.7% 0.0%   Added value   56.1 518.0 933.1 1,376.8 1,556.0 4,263.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -252 -586 -853 -701 -653 -206 -160 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -25.8% 5.9% 23.3% 29.3% 25.1% 42.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -19.4% 5.1% 23.9% 38.9% 34.8% 80.7% 0.0% 0.0%   ROI %   -28.2% 9.9% 49.4% 63.4% 50.9% 122.9% 0.0% 0.0%   ROE %   -35.3% 13.8% 49.8% 57.7% 41.7% 97.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   31.4% 30.2% 42.9% 59.6% 67.6% 62.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   864.8% -55.5% -10.7% -86.4% -172.9% -79.9% 0.0% 0.0%   Gearing %   94.2% 20.6% 12.2% 4.9% 1.4% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.2% 5.5% 4.1% 3.8% 1.7% 4.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.2 0.5 1.2 2.2 3.0 2.6 0.0 0.0   Current Ratio   0.2 0.5 1.2 2.2 3.0 2.6 0.0 0.0   Cash and cash equivalent   0.0 409.5 220.2 1,276.6 2,685.7 3,407.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -602.4 -503.9 261.2 1,271.9 2,485.3 3,835.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   19 173 311 344 311 533 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   19 173 311 344 306 533 0 0   EBIT / employee   -107 30 169 257 241 520 0 0   Net earnings / employee   -84 25 131 199 188 409 0 0